H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology H-index 114 Citations 51,177 510 World Ranking 39 National Ranking 2
Medicine H-index 95 Citations 39,149 467 World Ranking 4598 National Ranking 50

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Internal medicine
  • Antibiotics

The scientist’s investigation covers issues in Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Biofilm and Antibiotics. His Pseudomonas aeruginosa study integrates concerns from other disciplines, such as Chronic infection, Colistin and Virulence. His Microbiology research is multidisciplinary, incorporating perspectives in Quorum sensing, Pseudomonadaceae, Immune system and Bacteria.

His biological study spans a wide range of topics, including Respiratory disease, Lung, Sputum and Immunology. His work deals with themes such as In vitro, Antimicrobial, Chronic disease, Innate immune system and In vivo, which intersect with Biofilm. He combines subjects such as Combination therapy, Drug resistance and Intensive care medicine with his study of Antibiotics.

His most cited work include:

  • Antibiotic resistance of bacterial biofilms (1802 citations)
  • Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors (1089 citations)
  • Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. (786 citations)

What are the main themes of his work throughout his whole career to date?

Niels Høiby mostly deals with Microbiology, Pseudomonas aeruginosa, Cystic fibrosis, Immunology and Biofilm. Niels Høiby is interested in Antibiotics, which is a branch of Microbiology. His studies in Pseudomonas aeruginosa integrate themes in fields like Quorum sensing, Ciprofloxacin, Inflammation and Chronic infection, Immune system.

His Cystic fibrosis study which covers Lung that intersects with Pneumonia. His research integrates issues of Tobramycin, Antimicrobial and In vivo in his study of Biofilm. His Internal medicine research integrates issues from Gastroenterology, Surgery and Staphylococcus aureus.

He most often published in these fields:

  • Microbiology (64.84%)
  • Pseudomonas aeruginosa (62.35%)
  • Cystic fibrosis (48.76%)

What were the highlights of his more recent work (between 2014-2021)?

  • Pseudomonas aeruginosa (62.35%)
  • Microbiology (64.84%)
  • Cystic fibrosis (48.76%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Biofilm and Antibiotics. His Pseudomonas aeruginosa study is related to the wider topic of Bacteria. His work carried out in the field of Microbiology brings together such families of science as Wound healing and In vivo.

His Cystic fibrosis research incorporates elements of Gastroenterology, Paranasal sinuses, Antibody and Lung. His research in Biofilm intersects with topics in Inflammation, Chronic wound, Mucus and Pseudomonas. The Antibiotics study combines topics in areas such as Adjuvant, Pathogen, Multidrug tolerance and Intensive care medicine.

Between 2014 and 2021, his most popular works were:

  • Strategies for combating bacterial biofilm infections (375 citations)
  • ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014 (355 citations)
  • Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. (153 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Internal medicine
  • Antibiotics

His primary scientific interests are in Microbiology, Pseudomonas aeruginosa, Biofilm, Cystic fibrosis and Antibiotics. Niels Høiby interconnects Guideline and Innate immune system in the investigation of issues within Microbiology. Pseudomonas aeruginosa is a subfield of Bacteria that Niels Høiby investigates.

His work on Biofilm matrix as part of general Bacteria research is frequently linked to Penetration, bridging the gap between disciplines. His Biofilm research incorporates themes from Staining, Mutant, Intensive care medicine, Clinical microbiology and Pseudomonas. He has researched Cystic fibrosis in several fields, including Phenotype, Oxidative stress and Lung, Lung infection.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Antibiotic resistance of bacterial biofilms

Niels Høiby;Thomas Bjarnsholt;Michael Givskov;Søren Molin.
International Journal of Antimicrobial Agents (2010)

2763 Citations

Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors

Morten Hentzer;Hong Wu;Jens Bo Andersen;Kathrin Riedel.
The EMBO Journal (2003)

1470 Citations

Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound.

Morten Hentzer;Kathrin Riedel;Thomas B. Rasmussen;Arne Heydorn.
Microbiology (2002)

1095 Citations

Why chronic wounds will not heal: a novel hypothesis.

Thomas Bjarnsholt;Klaus Kirketerp-Møller;Peter Østrup Jensen;Kit G. Madsen.
Wound Repair and Regeneration (2008)

889 Citations

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

G. Döring;S. P. Conway;H. G. M. Heijerman;M. E. Hodson.
European Respiratory Journal (2000)

756 Citations

The clinical impact of bacterial biofilms

Niels Høiby;Oana Ciofu;Helle Krogh Johansen;Zhi-jun Song.
International Journal of Oral Science (2011)

698 Citations

Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients

Thomas Bjarnsholt;Peter Østrup Jensen;Mark J. Fiandaca;Jette Pedersen.
Pediatric Pulmonology (2009)

696 Citations

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

Anders Folkesson;Lars Jelsbak;Lei Yang;Lei Yang;Helle Krogh Johansen.
Nature Reviews Microbiology (2012)

635 Citations

Pseudomonas aeruginosa biofilms in cystic fibrosis

Niels Høiby;Oana Ciofu;Thomas Bjarnsholt.
Future Microbiology (2010)

591 Citations

OXA-type carbapenemases

Jan Walther-Rasmussen;Niels Høiby.
Journal of Antimicrobial Chemotherapy (2006)

590 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Niels Høiby

Michael Givskov

Michael Givskov

University of Copenhagen

Publications: 188

Thomas Bjarnsholt

Thomas Bjarnsholt

University of Copenhagen

Publications: 138

Scott A. Rice

Scott A. Rice

Nanyang Technological University

Publications: 123

Staffan Kjelleberg

Staffan Kjelleberg

Nanyang Technological University

Publications: 107

Paul Stoodley

Paul Stoodley

The Ohio State University

Publications: 84

Helle Krogh Johansen

Helle Krogh Johansen

University of Copenhagen

Publications: 82

Søren Molin

Søren Molin

Technical University of Denmark

Publications: 81

Antonio Oliver

Antonio Oliver

Instituto de Salud Carlos III

Publications: 81

Tim Tolker-Nielsen

Tim Tolker-Nielsen

University of Copenhagen

Publications: 78

Robert E. W. Hancock

Robert E. W. Hancock

University of British Columbia

Publications: 70

Liang Yang

Liang Yang

Southern University of Science and Technology

Publications: 70

Burkhard Tümmler

Burkhard Tümmler

Hannover Medical School

Publications: 69

Tom Coenye

Tom Coenye

Ghent University

Publications: 62

Gerd Döring

Gerd Döring

University of Tübingen

Publications: 61

Leo Eberl

Leo Eberl

University of Zurich

Publications: 59

Something went wrong. Please try again later.